| Ms Elizabeth Ann Gold, APN | |
|
99 Beauvoir Ave Fl 5, Summit, NJ 07901-3533 | |
| (908) 522-5914 | |
| (908) 522-5845 |
| Full Name | Ms Elizabeth Ann Gold |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 11 Years |
| Location | 99 Beauvoir Ave Fl 5, Summit, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215360953 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LA2100X | Nurse Practitioner - Acute Care | 26NJ00454100 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Morristown Medical Center | Morristown, NJ | Hospital |
| Overlook Medical Center | Summit, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Practice Associates Medical Group | 5890703177 | 1116 |
News Archive
Genentech, a member of the Roche Group, confirmed that following the reviews of Avastin® (bevacizumab) in metastatic breast cancer by the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA), the following regulatory announcements were made by the individual health authorities:
Results from a US study suggest that a state-supported program of overdose education and nasal naloxone distribution for potential bystanders can help reduce opioid-related overdose deaths.
Phase II trial findings have ruled out a combination of erlotinib and everolimus for advanced non-small-cell lung cancer patients with progression after chemotherapy.
Middle-age men and women who have cardiovascular issues, such as high cholesterol and high blood pressure, may not only be at risk for heart disease, but for an increased risk of developing early cognitive and memory problems as well.
The recent dramatic increase in the fall death rate in older Americans is likely the effect of improved reporting quality, according to a new report from the Johns Hopkins Center for Injury Research and Policy.
› Verified 7 days ago
| Entity Name | Atlantic Neurosurgical Specialists Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568553287 PECOS PAC ID: 7517951866 Enrollment ID: O20040412000283 |
News Archive
Genentech, a member of the Roche Group, confirmed that following the reviews of Avastin® (bevacizumab) in metastatic breast cancer by the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA), the following regulatory announcements were made by the individual health authorities:
Results from a US study suggest that a state-supported program of overdose education and nasal naloxone distribution for potential bystanders can help reduce opioid-related overdose deaths.
Phase II trial findings have ruled out a combination of erlotinib and everolimus for advanced non-small-cell lung cancer patients with progression after chemotherapy.
Middle-age men and women who have cardiovascular issues, such as high cholesterol and high blood pressure, may not only be at risk for heart disease, but for an increased risk of developing early cognitive and memory problems as well.
The recent dramatic increase in the fall death rate in older Americans is likely the effect of improved reporting quality, according to a new report from the Johns Hopkins Center for Injury Research and Policy.
› Verified 7 days ago
| Entity Name | Practice Associates Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427016385 PECOS PAC ID: 5890703177 Enrollment ID: O20060330000690 |
News Archive
Genentech, a member of the Roche Group, confirmed that following the reviews of Avastin® (bevacizumab) in metastatic breast cancer by the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA), the following regulatory announcements were made by the individual health authorities:
Results from a US study suggest that a state-supported program of overdose education and nasal naloxone distribution for potential bystanders can help reduce opioid-related overdose deaths.
Phase II trial findings have ruled out a combination of erlotinib and everolimus for advanced non-small-cell lung cancer patients with progression after chemotherapy.
Middle-age men and women who have cardiovascular issues, such as high cholesterol and high blood pressure, may not only be at risk for heart disease, but for an increased risk of developing early cognitive and memory problems as well.
The recent dramatic increase in the fall death rate in older Americans is likely the effect of improved reporting quality, according to a new report from the Johns Hopkins Center for Injury Research and Policy.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Elizabeth Ann Gold, APN 1005 Tompkins Ave, South Plainfield, NJ 07080-2238 Ph: (908) 406-5206 | Ms Elizabeth Ann Gold, APN 99 Beauvoir Ave Fl 5, Summit, NJ 07901-3533 Ph: (908) 522-5914 |
News Archive
Genentech, a member of the Roche Group, confirmed that following the reviews of Avastin® (bevacizumab) in metastatic breast cancer by the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA), the following regulatory announcements were made by the individual health authorities:
Results from a US study suggest that a state-supported program of overdose education and nasal naloxone distribution for potential bystanders can help reduce opioid-related overdose deaths.
Phase II trial findings have ruled out a combination of erlotinib and everolimus for advanced non-small-cell lung cancer patients with progression after chemotherapy.
Middle-age men and women who have cardiovascular issues, such as high cholesterol and high blood pressure, may not only be at risk for heart disease, but for an increased risk of developing early cognitive and memory problems as well.
The recent dramatic increase in the fall death rate in older Americans is likely the effect of improved reporting quality, according to a new report from the Johns Hopkins Center for Injury Research and Policy.
› Verified 7 days ago
Cynthia E Cross, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 99 Beauvoir Ave, Summit, NJ 07901 Phone: 973-971-5595 | |
Elfie Wegner, RN P Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 33 Overlook Rd, Summit, NJ 07901 Phone: 973-971-7184 | |
Ms. Danielle Knight, APN-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 11 Overlook Road, Mac Ii Building, Suite Ll 101, Summit, NJ 07901 Phone: 908-522-5900 Fax: 908-522-5544 | |
Darnell Hassan Stith Jr., APN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 99 Beauvoir Ave, Summit, NJ 07901 Phone: 908-522-2000 | |
Amy Lynne Ishak, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 99 Beauvoir Ave, Summit, NJ 07901 Phone: 908-522-5310 | |
Sarah Barnett, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1 Springfield Ave, Pulmonary And Allergy Associates, Summit, NJ 07901 Phone: 908-934-0555 Fax: 908-934-0558 | |
Jennifer Lillian O'neill, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 33 Overlook Rd Ste 201, Summit, NJ 07901 Phone: 908-522-5040 Fax: 908-522-5041 |